Specializing in lymphoid malignancies, including:

• Lymphoma (Hodgkin & Non-Hodgkin subtypes)
• Multiple Myeloma
• Chronic Lymphocytic Leukemia (CLL)
• Other clonal lymphoproliferative disorders

Lugui Qiu, M.D.

Distinguished clinical expert; State Council Expert; Committee Member, International Myeloma Society (IMS); Expert Panel Member, International Myeloma Working Group (IMWG); Chair, Hematologic Oncology Committee, Chinese Anti-Cancer Association. 

With 30+ years of clinical and translational research experience in hematology, Dr. Qiu Lugui stands as one of China's foremost leaders in lymphoma research.

His pioneering work focuses on:

• Molecular pathogenesis and targeted therapies for lymphoid malignancies
• Hematopoietic stem cell transplantation (clinical optimization & mechanistic studies)

Gang An, M.D.

Director, Lymphoma Ward. 2020 China Young Scientist in Oncology. Specializing in hematologic malignancies, with a focus on multiple myeloma and lymphoma.